July 10, 2024Journal of Antimicrobial Chemotherapy

Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes

View Full Paper

Ask AI

Bookmark

Abstract

To describe the management of haematological patients experiencing prolonged SARS-CoV-2 viral shedding, as the optimal management strategy for this condition remains undetermined.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gras et al. (2024) studied this question.

synapsesocial.com/papers/68e60be9b6db64358759ed11 https://doi.org/10.1093/jac/dkae237

View Full Paper

Ask AI

Bookmark

Abstract

To describe the management of haematological patients experiencing prolonged SARS-CoV-2 viral shedding, as the optimal management strategy for this condition remains undetermined.

Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes

Abstract

Discussion

Cite This Study

Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes

Abstract

Discussion

Cite This Study

Keep reading

Keep reading